Skip to main content
Premium Trial:

Request an Annual Quote

Nanosphere's Shares Drop More Than 35 Percent

NEW YORK (GenomeWeb News) – Shares of molecular diagnostics firm Nanosphere fell more than 35 percent on Monday, though there was no news or regulatory filings that would account for such a sell off.

The Dow Jones Industrial Average closed down .4 percent, and almost all of the firms in the GenomeWeb Daily News Index finished in negative territory for the day.

However, Nanosphere’s stock took the biggest hit by far of the firms covered by GWDN. Its shares closed at $4.26 on the Nasdaq, down 37 percent for the day. During the trading session, it hit a low of $4.17. Trading volume was nearly triple its average of around 67,000 shares per trading session.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.